Nuvectis Pharma, Inc. (NVCT) Misses Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts NVCT Hot Sheet
Join SI Premium – FREE
Nuvectis Pharma, Inc. (NASDAQ: NVCT) reported Q3 EPS of ($0.37), $0.03 worse than the analyst estimate of ($0.34).
For earnings history and earnings-related data on Nuvectis Pharma, Inc. (NVCT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nuvectis Pharma (NVCT) PT Raised to $39 at H.C. Wainwright
- Paychex beats fourth quarter EPS estimates, stock slides
- FedEx (FDX) PT Lowered to $397 at Bernstein SocGen Group
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
